Cargando…
GOECP/SEOR radiotherapy guidelines for small-cell lung cancer
Small cell lung cancer (SCLC) accounts for approximately 20% of all lung cancers. The main treatment is chemotherapy (Ch). However, the addition of radiotherapy significantly improves overall survival (OS) in patients with non-metastatic SCLC and in those with metastatic SCLC who respond to Ch. Prop...
Autores principales: | Couñago, Felipe, de la Pinta, Carolina, Gonzalo, Susana, Fernández, Castalia, Almendros, Piedad, Calvo, Patricia, Taboada, Begoña, Gómez-Caamaño, Antonio, Guerra, José Luis López, Chust, Marisa, González Ferreira, José Antonio, Álvarez González, Ana, Casas, Francesc |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7968106/ https://www.ncbi.nlm.nih.gov/pubmed/33767969 http://dx.doi.org/10.5306/wjco.v12.i3.115 |
Ejemplares similares
-
GOECP/SEOR radiotherapy guidelines for thymic epithelial tumours
por: Rico, Mikel, et al.
Publicado: (2021) -
GOECP/SEOR radiotheraphy guidelines for non-small-cell lung cancer
por: Rodríguez De Dios, Núria, et al.
Publicado: (2022) -
GOECP/SEOR clinical recommendations for lung cancer radiotherapy during the COVID-19 pandemic
por: Couñago, Felipe, et al.
Publicado: (2020) -
GOECP/SEOR clinical guidelines on radiotherapy for malignant pleural mesothelioma
por: Luna, Javier, et al.
Publicado: (2021) -
Postoperative radiotherapy in resected non-small cell lung cancer: The never-ending story
por: Serrano, Javier, et al.
Publicado: (2021)